COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,637 Articles (22,913 medRxiv, 8,724 bioRxiv)

Most recent first Previous |  Page 2263: Articles 22621-22630  | Next

A population-based seroprevalence survey of severe acute respiratory syndrome coronavirus 2 infection in Beijing, China
Wang, X., Gao, W., Cui, S., Zhang, Y., Zheng, K., Ke, J., Lv, J., Yu, C., Sun, D., Wang, Q., Li, L.
10.1101/2020.09.23.20197756 — Posted: 2020-09-23
Microfluidic Affinity Profiling reveals a Broad Range of Target Affinities for Anti-SARS-CoV-2 Antibodies in Plasma of Covid Survivors
Schneider, M. M., Emmenegger, M., Xu, C. K., Condado Morales, I., Turelli, P., Zimmermann, M. R., Frey, B. M., Fiedler, S., Denninger, V., Meisl, G., Kosmoliaptsis, V., Fiegler, H., Trono, D., Knowles, T. P. J., Aguzzi, A. A.
10.1101/2020.09.20.20196907 — Posted: 2020-09-23 Discussion: Onsite
At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults
Chartier, K. G., Guidry, J. P. D., Lee, C. A.
10.1101/2020.09.20.20197608 — Posted: 2020-09-23
DOSING OF THROMBOPROPHYLAXIS AND MORTALITY IN CRITICALLY ILL COVID-19 PATIENTS
Jonmarker, S., Hollenberg, J., Dahlberg, M., Stackelberg, O., Litorell, J., Everhov, A., Järnbert-Pettersson, H., Söderberg, M., Grip, J., Schandl, A., Gunther, M., Cronhjort, M.
10.1101/2020.09.17.20195867 — Posted: 2020-09-23
Cold plasma for SARS-CoV-2 Inactivation
Chen, Z., Garcia, G., Arumugaswami, V., Wirz, R. E.
10.1101/2020.09.17.20192872 — Posted: 2020-09-23
Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account
Malecki, M., Luesebrink, J., Wendel, A., Mattner, F.
10.1101/2020.09.18.20185744 — Posted: 2020-09-23
Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT)
Meyer, B., Reimerink, J., Torriani, G., Brouwer, F., Godeke, G.-J., Yerly, S., Hoogerwerf, M., Vuilleumier, N., Kaiser, L., Eckerle, I., Reusken, C.
10.1101/2020.09.21.20191288 — Posted: 2020-09-23
Subclinical ocular inflammation in persons recovered from ambulatory COVID-19
Bakhoum, M. F., Ritter, M., Garg, A., Chan, A. X., Bakhoum, C. Y., Smith, D.
10.1101/2020.09.22.20128140 — Posted: 2020-09-23
An expert judgment model to predict early stages of the COVID-19 outbreak in the United States
McAndrew, T. C., Reich, N. G.
10.1101/2020.09.21.20196725 — Posted: 2020-09-23
Putting (Big) Data in Action: Saving Lives with Countrywide Population Movement Monitoring Using Mobile Devices during the COVID-19 Crisis
Szocska, M. K., Pollner, P., Schiszler, I., Joo, T., Palicz, T., McKee, M., Magyar Telekom Nyrt., , Telenor Magyarorszag Zrt., , Sohonyai, A., Szoke, J., Toth, A., Gaal, P.
10.1101/2020.09.21.20194019 — Posted: 2020-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).